SyntekaBio, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.00044 million compared to KRW 0.00044 million a year ago. Net loss was KRW 4,506.43 million compared to KRW 14,802.8 million a year ago.

Basic loss per share from continuing operations was KRW 333 compared to KRW 1,099 a year ago. Diluted loss per share from continuing operations was KRW 333 compared to KRW 1,099 a year ago. Basic loss per share was KRW 333 compared to KRW 1,099 a year ago.